Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The “Experts in Residence” scheme is managed by the Translational Research Office, the Business Partnerships Office and Oxford University Innovation. It aims to give Oxford's research community access to world-leading expertise and advice across multiple industry sectors. Scientists can arrange meetings with our experts to discuss their ideas and projects with no strings attached. We expect that this advice and support will help scientists develop the translational strategy for their projects/technologies.

View a brochure detailing the structure of the program, key stakeholders, testimonials, and a directory for researchers to learn more about the experts.

Our Experts

Book a meeting with one of our Experts in Residence

 Product Design in Biomedical Engineering 

Patrick Hall

 

Patrick Hall, Managing Director, Designing Science Ltd

 

 

 

Kerry Briggs.PNG

 

Kerry Briggs, Head of Medical, Kinneir Dufort

 

 

 

James Holmes.PNG

James Holmes, Head of Electronics, Kinneir Dufort

 

 

 

Rouzet Agaiby.PNG

 

Rouzet Agaiby, Associate Director, eg technology 

 

 

Imaging technologies 

Dr Jan Wolber

 

Dr Jan Wolber, Product Leader - Digital, GE Healthcare Pharmaceutical Diagnostics  

 

 

 

 Drug Discovery and development 

RachelGrimley_edited.PNG

 

Dr Rachel Grimley, Senior Vice President, Drug discovery, Cancer Research UK 

 

 

Simon J Hollingsworth

 

Professor Simon Hollingsworth, VP, Global Medicine Leader, AstraZeneca

 

                                 

Rachel Hemsley

Dr Rachel Hemsley, Global Head of Business Development, Xenogesis

 

 

 

 

Colin T Dourish

 

Dr Colin T Dourish, Director and Co-Owner of P1vital and P1vital Products 

 

 

 

 

Anthony Brown

 

Dr Anthony Brown, VP Business Development & Scientific Liaison, Carrick Therapeutics

 

 

 

Holger Hess Stumpp

 

 

Dr Holger Hess-Stumpp, Director, Strategic Alliance Manager Oncology, Bayer, 

 

 

 

DavidReynoldsExIRedited.PNG

 

 Professor David Reynolds, CEO of LoQus 23 and AstronauTx  

 

 

Tom Oakley

 

Dr Tom Oakley, VP EU Regulatory Affairs, Propharma Group 

 

 

Digital Health 

 Photo of Dr Steve Gardner

Dr Steve Gardner, Co-founder and CEO, PrecisionLife

 

 

 

Photo of Dr Veronique Bouchet

 

Dr Veronique Bouchet, Chief Medical Officer, PrecisionLife;

 

 

  

Anonymous profile photo

 

Paul O'Donohoe, Scientific Lead, eCOA and Mobile Health, Medidata Solutions;

 

 

 

Bobby Kaura

 

Bobby Kaura, Seed Investment, EMEA Outreach & International Development, Illumina Accelerator

 

 

 

Medical Technologies -  Regulatory and Market Access 

Toni Day

 

Dr Toni Day, Director of Quality and Regulatory Affairs at OrganOx

 

 

 

Richard Hall.PNG

 

Richard Hall, QMS Consultancy

 

 

 

BWS_edited.PNG
Ben Wensley-Stock
, Managing Director MPS-UK and Wensley Stock Ltd 

 

 

 

Steven Haken.PNG

 

Dr Steven Haken, Director at Odelle Technology

 

 

  

Diagnostics

Adam Hill

 

Dr Adam Hill, Ceo of Oncimmune

 

 

 

Clinical Research

Steve McConchiee

 

Dr Steve McConchie, CEO of Aptus

 

 

       

Photo of Matthew Reaney

 

 

Matthew Reaney, Head of Patient Centered Endpoints, Science & Analytical Teams, IQVIA

 

   

 

Photo of Professor Jeremy Kirk 

Professor Jeremy KirkR&D Director Birmingham Women and Children’s Hospital and former CD NIHR Clinical Research Network for West Midlands

 

 

Innovation and commercial opportunities

PaulCoxEdited.PNG

 

 Paul Cox, General Manager, Apellis Pharmaceuticals

 

 

Nicholas Duggan

 

 

Nicholas Duggan, Partner at Viadynamics

 

 

 

 

Joanne Hackett

 

  Dr Joanne Hackett, IZY Capital

 

 

 

 

Laura Ferguson

 

Dr Laura Ferguson, AstraZeneca

 

 

 

 

Karen Wai.PNG

 

Dr Karen Wai, KW Health Advisory